Company Pharmagreen Biotech Inc.

Equities

PHBI

US71716C1099

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 03:55:55 2024-04-25 pm EDT			5-day change	1st Jan Change
0.0007 ^USD	0.00%		-12.50%	+16.67%

Feb. 21	Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Jan. 09	Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Pharmagreen Biotech, Inc. is a Canada-based company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a wide variety of ailing conditions. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle with 60 enteric capsules. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its other nutraceutical products are in various development stages. Its subsidiaries include WFS Pharmagreen Inc, and 1155097 BC Ltd.

USD in Million	2022	Weight	2023	Weight	Delta
Cannabis Biotech Complex 100.0 %	0	nan %	0	100.0 %	-

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	nan %	0	100.0 %	-

Managers	Title	Age	Since
Peter Wojcik CEO	Chief Executive Officer	53	13-12-08
Terry Kwan DFI	Director of Finance/CFO	77	15-07-21
Ethan Styles CTO	Chief Tech/Sci/R&D Officer	-	22-09-21
Fawzia Afreen COO	Chief Operating Officer	58	17-12-31

Members of the board	Title	Age	Since
Peter Wojcik CEO	Chief Executive Officer	53	13-12-08
Terry Kwan DFI	Director of Finance/CFO	77	15-07-21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	663,645,739	578,911,453 ( 87.23 %)	0	87.23 %
Stock B	0	10,000	0	0

Name	Equities	%	Valuation
Peter Wojcik 5.286 %	35,077,500	5.286 %	35 078 $
Harry Larochelle 4.509 %	29,926,786	4.509 %	29 927 $
Wlaydyslaw Wojcik 1.918 %	12,730,000	1.918 %	12 730 $
Terry Kwan 0.7534 %	5,000,000	0.7534 %	5 000 $
Fawzia Afreen 0.3014 %	2,000,000	0.3014 %	2 000 $

Name	Equities	%	Valuation
Peter Wojcik 100.00 %	10,000	100.00 %	10 $

Pharmagreen Biotech, Inc.

2987 Blackbear Court

V4E 3A2, Coquitlam

+404-671-9253

http://www.pharmagreen.ca

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PHARMAGREEN BIOTECH INC.	+16.67%	465K
IQVIA HOLDINGS INC.	+1.33%	42.59B
MODERNA, INC.	+7.17%	40.65B
LONZA GROUP AG	+48.04%	40.57B
CELLTRION, INC.	-11.96%	26.77B
ICON PUBLIC LIMITED COMPANY	+7.76%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-24.97%	18.17B
MEDPACE HOLDINGS, INC.	+28.34%	12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.81%	11.7B
UNITED THERAPEUTICS CORPORATION	+7.32%	11.1B

Other Biotechnology & Medical Research